Senior Member
Join Date: Aug 2007
Location: Newport Beach, CA
Posts: 161
|
LBBC on bone health, node surgery and triple neg.
<TABLE style="BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" cellSpacing=0 cellPadding=3 width=630 align=center bgColor=#ffffff border=0><TBODY><TR><TD><TABLE cellSpacing=0 cellPadding=0 width="100%" border=0><TBODY><TR><TD> </TD></TR><TR><TD style="PADDING-RIGHT: 5px" align=right bgColor=#ffdb84> 4/9/08
</TD></TR><TR><TD style="PADDING-RIGHT: 15px; PADDING-LEFT: 15px; PADDING-BOTTOM: 15px; PADDING-TOP: 15px" bgColor=#efefef> Dear Vicki,
Read the Latest Breast Cancer News on Lbbc.org
- AIs and Bone Health - Phase III trial suggests postmenopausal women with estrogen receptor-positive, early-stage breast cancer could increase bone density lost from AIs.
- Axillary Node Surgery - Removing axillary lymph nodes may not be necessary for women with small tumors and few positive sentinel nodes, a recent study indicates.
Visit our website for more breast cancer news.
Survivor Profiles
From our website community for women recently diagnosed with breast cancer - Maria Matos, of Wilmington , Delaware , was the first person in her family to be diagnosed with any type of cancer. Read about how family and community support help Maria cope with a diagnosis of ductal carcinoma in situ.
From our website community for young women affected by breast cancer - When Janet Beatty learned she had breast cancer just six weeks before her wedding, she thought, "I don’t have time for this." At age 29, living in Chicago , breast cancer was the last thing Janet expected. Read about Janet’s diagnosis, treatment and her life today.
Treatment Update on Triple-Negative Breast Cancer Register now for our next national teleconference hosted in partnership with the Triple Negative Breast Cancer Foundation, Triple-Negative Breast Cancer: Research and Treatment Update, from 12:00 p.m. to 1:30 p.m. Eastern Daylight Time (EDT) on Friday, April 18.
Lisa A. Carey, MD, ScM, of the University of North Carolina Breast Center, will provide new information on triple-negative breast cancers, or cancers that test negative for the estrogen and progesterone receptor and HER2 protein, including: - The latest information, research and treatments for triple-negative breast cancer
- The causes of this diagnosis
- Factors that may make triple-negative disease more difficult to treat in early and advanced breast cancers
Visit our website for more information.
Warmly,
Jean
Jean A. Sachs, MSS, MLSP
LBBC Chief Executive Officer
Toll-free Survivors' Helpline: (888) 753-LBBC (5222) 354 West Lancaster Ave., Suite 224
Haverford, PA 19041
</TD></TR><TR><TD align=middle bgColor=#c6c7c6>
</TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE>
__________________
Diagnosed 12/03 at age 53
1.5cm tumor, ER-PR-, Her2 3+(rt side)
Stage 1B, Three negative nodes from Sentinel Node Biopsy
Paget's of the nipple, Infiltrating Ductal Carcinoma and DCIS of the rt breast
Bloom-Richardson score 8/9, P53+ 60-70%, Ki-67+ 30-40%
Skin-sparing mastectomy with immediate lat-flap reconstruction and saline implants, 1/04
Chemo: FAC, five sessions every three weeks Feb.-May 04, then switched to HTC weekly for 12 weeks, June-Aug 04
Zometa every 6 months for osteopenia, started April 09
|